Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial.

Jardiance (empagliflozin) - Eli Lilly, Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/42679726

Esben Laugesen; Kristian Løkke Funck; Liv Vernstrøm; Per Løgstrup Poulsen; Steffen Skovgaard Sørensen; Søren Gullaksen

Sep 2, 2026